Revenue $51.43B, up 1.4% on a year earlier. Premiums Revenue $41.70B, down 0.2%. Operating revenue $50.44B, down 0.5%. Diluted EPS $6.27 against $5.32.
| Q3 FY26 | Q2 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|---|
| Revenue | $51.43B | $50.47B | $50.71B | +1.4% |
| Operating income | $1.27B | $1.76B | $1.29B | -2.0% |
| Net income | $1.36B | $1.46B | $1.19B | +15.0% |
| Diluted EPS | $6.27 | $6.71 | $5.32 | |
| Operating cash flow | $1.27B | $1.91B | $1.14B | +11.6% |
| Capital expenditures | -$267.00M | -$287.00M | -$360.00M | |
| Free cash flow | $1.00B | $1.63B | $775.00M | +29.0% |
| Dividend per share | $1.72 | $1.71 | $1.71 |
| Q3 FY26 | Q3 FY25 | Year over year | |
|---|---|---|---|
| Premiums Revenue | $41.70B | $41.79B | -0.2% |
| Operating revenue | $50.44B | $50.71B | -0.5% |
| Health Benefits operating revenue | $43.36B | $42.20B | +2.7% |
| Carelon operating revenue | $19.30B | $18.30B | +5.5% |
The week's biggest guidance misses, KPI surprises and one chart.
Stock Atlas, “Elevance Health (ELV) Q3 FY26 earnings: results and KPIs”, stockatlas.com/companies/ELV/earnings/2026-q3/, data as of 3 November 2026. Links to this page are welcome.
